86 related articles for article (PubMed ID: 3484663)
1. Lack of natural killer cell activity in hairy cell leukemia patients and partial restoration with interleukin-2.
Hooper WC; Barth RF; Shah NT
Cancer; 1986 Mar; 57(5):988-93. PubMed ID: 3484663
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
Reiter Z; Tomson S; Ozes ON; Taylor MW
Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405
[TBL] [Abstract][Full Text] [Related]
3. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia.
Ruco LP; Procopio A; Maccallini V; Calogero A; Uccini S; Annino L; Mandelli F; Baroni CD
Blood; 1983 Jun; 61(6):1132-7. PubMed ID: 6220750
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
Trentin L; Zambello R; Agostini C; Ambrosetti A; Chisesi T; Raimondi R; Bulian P; Pizzolo G; Semenzato G
Blood; 1990 Apr; 75(7):1525-30. PubMed ID: 2317560
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
[TBL] [Abstract][Full Text] [Related]
7. Natural killer lymphocytes in hairy cell leukemia: presence of phenotypically identifiable cells with defective functional activity.
Smith BR; Rosenthal DS; Ault KA
Exp Hematol; 1985 Mar; 13(3):189-93. PubMed ID: 3884356
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell function and malignant cell phenotype in hairy cell leukaemia.
Ogmundsdóttir HM; Thorsteinsson L; Sigfússon A; Sveinsdóttir S; Björnsson S; Eyjólfsson G; Jóhannesson GM; Jensson O
APMIS; 1992 Jan; 100(1):10-20. PubMed ID: 1536717
[TBL] [Abstract][Full Text] [Related]
9. Decreased NK activity in hairy cell leukemia (HCL): an analysis at the cellular level.
Fontana L; De Rossi G; De Sanctis G; Ensoli F; Lopez M; Annino L; Mandelli F
Blut; 1986 Aug; 53(2):107-13. PubMed ID: 3730622
[TBL] [Abstract][Full Text] [Related]
10. Hairy cell leukemia: absence of natural killer activity and of interleukin 1 release in OKM-1+ spleen hairy cells.
Ruco LP; Stoppacciaro A; Valtieri M; Procopio A; Uccini S; Baroni CD
Clin Immunol Immunopathol; 1983 Jan; 26(1):47-55. PubMed ID: 6603305
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytes from patients with hairy cell leukaemia enable the distinction of two separate subpopulations of activated lymphocyte killer cells generated in mixed lymphocyte culture.
Werkmeister JA; Boyd AW; Triglia T; Burns GF
Clin Exp Immunol; 1985 Jul; 61(1):103-8. PubMed ID: 2931219
[TBL] [Abstract][Full Text] [Related]
12. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
Griffiths SD; Cawley JC
Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
[TBL] [Abstract][Full Text] [Related]
13. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
Nielsen B; Hokland P; Ellegaard J; Hasselbalch H; Hokland M
Leuk Res; 1989; 13(6):451-6. PubMed ID: 2770329
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
Chang WC; Hsiao MH; Pattengale PK
Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
[TBL] [Abstract][Full Text] [Related]
15. Hairy cell leukemia: morphological, cytochemical, immunological and ultrastructural features; and leukopheresis therapy.
Shih LY; Sung YT
Taiwan Yi Xue Hui Za Zhi; 1981 Sep; 80(9):961-70. PubMed ID: 6948090
[No Abstract] [Full Text] [Related]
16. Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events.
Trentin L; Ambrosetti A; Zambello R; Agostini C; Masciarelli M; Vinante F; Chilosi M; Pizzolo G; Cetto G; Semenzato G
Leuk Res; 1987; 11(9):843-7. PubMed ID: 3499539
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity.
Chilosi M; Semenzato G; Cetto G; Ambrosetti A; Fiore-Donati L; Perona G; Berton G; Lestani M; Scarpa A; Agostini C
Blood; 1987 Nov; 70(5):1530-5. PubMed ID: 3117133
[TBL] [Abstract][Full Text] [Related]
18. Immunologic and clinical aspects of natural killer cells in human leukemia.
Lotzová E; Savary CA; Pollock RE; Fuchshuber P
Nat Immun Cell Growth Regul; 1990; 9(3):173-81. PubMed ID: 2370877
[TBL] [Abstract][Full Text] [Related]
19. Alpha-interferon activates the natural killer system in patients with hairy cell leukemia.
Semenzato G; Pizzolo G; Agostini C; Ambrosetti A; Zambello R; Trentin L; Luca M; Masciarelli M; Chilosi M; Vinante F
Blood; 1986 Jul; 68(1):293-6. PubMed ID: 3719101
[TBL] [Abstract][Full Text] [Related]
20. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C
J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]